PALLAS Laser for Skin Diseases
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorSzeged University
About this trial
The primary objective of this study is to get clinical experiences with the PALLAS laser in the treatment of skin conditions that respond well to UV light (vitiligo, psoriasis, alopecia areata, atopic dermatitis).
The secondary objective is to assess how user-friendly is the Pallas laser in the treatment of skin diseases.
The patient in the trial will receive UVB laser treatment (2 treatments per week for up to 3 months). The treatments will be carried out by the doctors participating in the trial.
The treatment takes approximately 10 minutes per session, and can last up to 3 months per patient.
Photographic documentation of the lesions to be treated and the lesions treated is taken at the start of the examination and then once a month.
At the end of the study, the patient rates the treatment and improvement on a Patient Satisfaction Scale.
Eligibility criteria
Qualifiers
The subject understands the information provided, gives informed consent to participate in the study and is deemed by the investigator to be able to participate,
a skin condition that is expected to respond well to targeted UVB treatment,
a signed consent form.
Disqualifiers
Patient under 18 years of age,
pregnancy
epilepsy,
fever, infectious diseases,
Trial design
Treatments tested in this trial
- UVB laser treatment
Treatment groups
50 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov